AXIOM INVESTORS LLC /DE - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 443 filers reported holding REPLIGEN CORP in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
AXIOM INVESTORS LLC /DE ownership history of REPLIGEN CORP
ValueSharesWeighting
Q2 2024$5,155,098
-41.8%
40,894
-15.1%
0.04%
-41.6%
Q1 2024$8,857,955
-19.7%
48,162
-26.5%
0.08%
-57.7%
Q1 2023$11,030,274
-32.9%
65,516
-32.5%
0.18%
-43.7%
Q4 2022$16,429,165
-67.1%
97,036
-63.6%
0.32%
-69.2%
Q3 2022$49,945,000
+516.6%
266,927
+435.2%
1.05%
+331.3%
Q2 2022$8,100,000
-45.1%
49,875
-36.4%
0.24%
-30.4%
Q1 2022$14,748,000
-40.5%
78,408
-16.2%
0.35%
-23.3%
Q4 2021$24,768,000
+18.6%
93,519
+29.4%
0.46%
+31.9%
Q3 2021$20,891,000
+405.7%
72,289
+249.3%
0.34%
+422.7%
Q2 2021$4,131,000
-25.2%
20,693
-27.2%
0.07%
-34.0%
Q1 2021$5,526,000
-40.4%
28,425
-41.2%
0.10%
-31.5%
Q4 2020$9,270,000
-8.5%
48,375
-29.6%
0.15%
-11.0%
Q3 2020$10,136,000
+49.3%
68,702
+25.1%
0.16%
+22.4%
Q2 2020$6,790,000
+108.1%
54,927
+62.5%
0.13%
+61.4%
Q1 2020$3,263,000
-10.4%
33,800
-14.1%
0.08%
-2.4%
Q4 2019$3,641,000
+31.5%
39,365
+9.1%
0.08%
+13.3%
Q3 2019$2,768,000
+194.2%
36,090
-24.0%
0.08%
+226.1%
Q4 2014$941,000
+9.0%
47,500
+9.5%
0.02%
+9.5%
Q3 2014$863,000
-54.1%
43,362
-47.4%
0.02%
-52.3%
Q2 2014$1,880,000
+31.3%
82,500
-25.9%
0.04%
+29.4%
Q1 2014$1,432,000
-37.5%
111,336
-33.8%
0.03%
-44.3%
Q4 2013$2,293,000168,1000.06%
Other shareholders
REPLIGEN CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Conestoga Capital Advisors, LLC 1,040,233$31,581,0002.16%
WALL STREET ASSOCIATES 697,600$21,179,0002.00%
APIS CAPITAL ADVISORS, LLC 40,300$1,223,0001.67%
D L CARLSON INVESTMENT GROUP INC 109,535$3,325,0001.18%
TAMRO Capital Partners LLC 530,690$16,112,0001.11%
Matarin Capital Management, LLC 109,848$3,334,985,0001.01%
AWM Investment Company, Inc. 230,000$6,983,0000.97%
FALCON POINT CAPITAL, LLC 35,533$1,079,0000.84%
DRILL CRAIG A 21,400$650,0000.74%
Pier Capital, LLC 160,601$4,876,0000.73%
View complete list of REPLIGEN CORP shareholders